Straumann Holding AGXSWX:STMN +1.81%99 Net Margin % is 9.50% as of Dec. 2025, which is 50% below its 10-year median of 18.97. GuruFocus rates XSWX:STMN with a GF Score™ of 99/100 and a GF Value™ of CHF136.90 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Straumann Holding AG ranks better than 80.78% on this metric.
The historical rank and industry rank for Straumann Holding AG's Net Margin % or its related term are showing as below:
XSWX:STMN'
s Net Margin % Range Over the Past 10 Years
Min: 6.4 Med: 18.97 Max: 25.14
Current: 13.66
XSWX:STMN's Net Margin % is ranked better than 80.78% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs XSWX:STMN: 13.66
Straumann Holding AG (XSWX:STMN) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Straumann Holding AG Net Margin % Related Terms
Straumann Holding AG Net Margin % Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:STMN vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Net Margin % distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (XSWX:STMN) has a Net Margin % of 9.50% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Straumann Holding AG and its competitors. This is 50% below median its historical median of 18.97. Over the past decade, Straumann Holding AG's Net Margin % has ranged from 6.40 to 25.14. According to the industry distribution chart, Straumann Holding AG ranks #157 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 19.2%.
Is Straumann Holding AG's Net Margin % too high?
Straumann Holding AG's current Net Margin % of 9.50% is 50% below median its 10-year median of 18.97. Over the past 10 years, this metric has ranged from a low of 6.40 to a high of 25.14. The Medical Devices & Instruments industry median Net Margin % is 2.07. Straumann Holding AG's value of 9.50% is 358.9% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #157 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Straumann Holding AG has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #157 out of 817 companies for Net Margin %. This places Straumann Holding AG in the top 19% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Straumann Holding AG's value of 9.50% is 358.9% above this benchmark. Historically, Straumann Holding AG's own Net Margin % has ranged from 6.40 to 25.14 over the past decade. While the company's 10-year median is 18.97 vs. the industry median of 2.07, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current Net Margin % of 9.50% is 358.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current Net Margin % is 9.50%, which is 50% below median its own 10-year median of 18.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.90, compared to a current price of CHF106.80 — trading 22% below its estimated fair value. The current Net Margin % is 9.50%, which is 50% below median its 10-year median of 18.97 and 358.9% above the Medical Devices & Instruments industry median of 2.07. Straumann Holding AG's overall GF Score™ is 99/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Net Margin % is 9.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.80 is trading 22% below its estimated GF Value™ of CHF136.90.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
Net Margin %: 9.50% (50% below median its 10-year median of 18.97)
GF Value™: CHF136.90 vs. price of CHF106.80 (22% below fair value)
Industry Position: 358.9% above the Medical Devices & Instruments median (#157 of 817)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
99GF Score
Get the complete analysis for XSWX:STMN
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
